Barbara Slusher explains the hit-to-lead optimization process, high-throughput screening, and the role of AI and organoids in ...

Drug Target Review has launched an updated website to improve access to content across early-stage drug discovery, alongside ...

Functional genomics is central to modern drug discovery, yet high attrition rates persist. In this article, Dr Salman ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing innovative combination therapies for high-impact indications, today announced it has been named the winner ...

This eBook is designed to deliver both strategic insight and practical guidance. It opens with a White Paper informed by ...

In 2026, AI moved from experimental promise to clinical reality, delivering breakthroughs in drug discovery, emergency diagnostics, and workflow automation. From Insilico Medicine’s rapid development ...

An ELRIG webinar has explored how cell-based screening supports drug discovery, from early target validation to advanced ...

Insilico Medicine announced LabClaw, an intelligent laboratory operating system designed to enable autonomous coordination ...

When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...

Drug repurposing could help find a treatment for multiple sulfatase deficiency, a rare genetic disease that currently has no ...